What top creators are saying about Rhythm Pharmaceuticals, Inc.(RYTM)

Biopharmaceutical company for rare genetic diseases

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Rhythm Pharmaceuticals, Inc..

Bearish
avg -0.30
0 bullish0 neutral1 bearish

Top creators covering Rhythm Pharmaceuticals, Inc. (RYTM)

The 1 sources with the most insights about Rhythm Pharmaceuticals, Inc. on Kazuha.

Latest insights about Rhythm Pharmaceuticals, Inc. (RYTM)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Bearish

Analyst holds a small position but doubts the success of their Angelman syndrome drug.

Martin Shkreli
7/20/26 -4%
Martin ShkreliYouTube7 hours ago

Discussed alongside Rhythm Pharmaceuticals, Inc. (RYTM)

Other assets that creators frequently mention in the same content as Rhythm Pharmaceuticals, Inc..

Frequently asked

Which podcasters and creators cover Rhythm Pharmaceuticals, Inc. (RYTM) the most?

The most active sources covering Rhythm Pharmaceuticals, Inc. (RYTM) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Rhythm Pharmaceuticals, Inc. (RYTM) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Rhythm Pharmaceuticals, Inc. (RYTM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Rhythm Pharmaceuticals, Inc. (RYTM)?

Creators covering Rhythm Pharmaceuticals, Inc. (RYTM) most frequently also discuss HUBS, AMD, MARA, TXG, SION. See the "Discussed alongside" section above for full asset pages.